Achillion Pharmaceuticals - 48 Year Dividend History | ACHN

Historical dividend payout and yield for Achillion Pharmaceuticals (ACHN) since 1971. The current TTM dividend payout for Achillion Pharmaceuticals (ACHN) as of June 24, 2019 is $0.00. The current dividend yield for Achillion Pharmaceuticals as of June 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.386B $0.015B
ACHILLION PHARMACEUTICALS, INC. is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The company's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease -- HIV, hepatitis and resistant bacterial infections. Achillion sees significant competitive advantages in developing anti-infective drugs compared to developing drugs in other therapeutic areas. The emergence of drug resistance seen with current antiviral and antibacterial therapies creates a continuing need for new drugs, providing a large and growing potential business opportunity. In addition, development cycle times tend to be somewhat shorter in infectious disease than other therapeutic areas, and early drug development results tend to be more predictive of longer term results.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.734B 12.75
Gilead Sciences (GILD) United States $87.764B 10.66
Bio-Techne Corp (TECH) United States $7.796B 53.19